Stryker Corp.’s surprising acquisition of Mako Surgical for $1.41 billion provided a boost for some medical device manufacturers. "This surprising announcement will have a positive impact on how the Street will view merger and acquisition opportunities among the remaining robotic surgical instrument companies, as Stryker's strategic direction as well as its willingness to pay will likely re-energize investors' sentiments on robotic surgical instrument companies that had been generally considered to face headwinds in increasingly low-cost-focused future of health care," wrote Janney Capital Markets analyst Spencer Nam.
Accuray Incorporated (NASDAQ: ARAY) shares traded in the range of $7.04 to $7.17 Wednesday before settling to close at $7.12, an increase of 1.86 percent. The stock appears to be facing some resistance at $7.19 with some support at the $6.80 and $6.37 levels. Shares of Accuray have gained approximately 10.0 percent in 2013.
More information on Accuray and access to the free equity report can be found at:
Hansen Medical, Inc. (NASDAQ: HNSN) shares traded in the range of $1.64 to $1.89 Wednesday before settling to close at $1.85, an increase of 14.91 percent. The stock appears to be facing some resistance at the $1.90 and $1.96 levels with some support at $1.77. Shares of Hansen Medical have fallen approximately 11.0 percent in 2013.
More information on Hansen Medical and access to the free equity report can be found at:
Intuitive Surgical, Inc. (NASDAQ: ISRG) shares traded in the range of $365.54 to $379.99 Wednesday before settling to close at $367.31, an increase of 0.94 percent. The stock appears to be facing some resistance at the $372.50, $385.14 and $394.63 levels. Shares of Intuitive Surgical have fallen approximately 25.0 percent in 2013.
More information on Intuitive Surgical and access to the free equity report can be found at:
Stereotaxis Inc. (NASDAQ: STXS) shares traded in the range of $3.40 to $3.72 Wednesday before settling to close at $3.43, an increase of 8.20 percent. The stock appears to be facing some resistance at the $3.47 and $5.73 levels with some support at $1.79. Shares of Stereotaxis have gained approximately 35.0 percent in 2013.
More information on Stereotaxis and access to the free equity report can be found at:
Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.
Activate your always free membership by signing up at www.WallStreetFundamentals.com today.
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.
Wall Street Fundamentals
Leave a comment...